Search research articles
Contact Us
Filters
Showing results (51-60 of 63) with videos related to
Page
of 7
Sort By:
Movement Disorders Clinical Practice
|
January 24, 2020
Characterizing White Matter in Huntington's Disease
Sarah Gregory, Eileanoir Johnson, Lauren M Byrne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 30, 2025
Advertising to Healthcare Professionals: Insights from Parkinson's Disease in the Movement Disorders Journal
Augusto Rachão, António Silva, Luísa Prada, et al.
Scientific Reports
|
February 11, 2021
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's disease
Zhen-Yi Andy Ou, Lauren M Byrne, Filipe B Rodrigues, et al.
Science Translational Medicine
|
September 14, 2018
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease
Lauren M Byrne, Filipe B Rodrigues, Eileanor B Johnson, et al.
Journal of Medical Internet Research
|
June 28, 2022
A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study
Florian Lipsmeier, Cedric Simillion, Atieh Bamdadian, et al.
Journal of Huntington'S Disease
|
March 7, 2022
Safety and Feasibility of Research Lumbar Puncture in Huntington's Disease: The HDClarity Cohort and Bioresource
Filipe B Rodrigues, Gail Owen, Swati Sathe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 24, 2018
Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life
Tiago A Mestre, Noelle E Carlozzi, Aileen K Ho, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations
Tiago A Mestre, Monica Busse, Aileen M Davis, et al.
Science Translational Medicine
|
December 17, 2020
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease
Filipe B Rodrigues, Lauren M Byrne, Rosanna Tortelli, et al.
BJU International
|
May 28, 2021
Growth and renal function dynamics of renal oncocytomas in patients on active surveillance
Joana B Neves, Rebecca Varley, Stefano Agnesi, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 63) with videos related to
Sort By:
Page
of 7
Movement Disorders Clinical Practice
|
January 24, 2020
Characterizing White Matter in Huntington's Disease
Sarah Gregory, Eileanoir Johnson, Lauren M Byrne, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
October 30, 2025
Advertising to Healthcare Professionals: Insights from Parkinson's Disease in the Movement Disorders Journal
Augusto Rachão, António Silva, Luísa Prada, et al.
Scientific Reports
|
February 11, 2021
Brain-derived neurotrophic factor in cerebrospinal fluid and plasma is not a biomarker for Huntington's disease
Zhen-Yi Andy Ou, Lauren M Byrne, Filipe B Rodrigues, et al.
Science Translational Medicine
|
September 14, 2018
Evaluation of mutant huntingtin and neurofilament proteins as potential markers in Huntington's disease
Lauren M Byrne, Filipe B Rodrigues, Eileanor B Johnson, et al.
Journal of Medical Internet Research
|
June 28, 2022
A Remote Digital Monitoring Platform to Assess Cognitive and Motor Symptoms in Huntington Disease: Cross-sectional Validation Study
Florian Lipsmeier, Cedric Simillion, Atieh Bamdadian, et al.
Journal of Huntington'S Disease
|
March 7, 2022
Safety and Feasibility of Research Lumbar Puncture in Huntington's Disease: The HDClarity Cohort and Bioresource
Filipe B Rodrigues, Gail Owen, Swati Sathe, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
March 24, 2018
Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life
Tiago A Mestre, Noelle E Carlozzi, Aileen K Ho, et al.
Movement Disorders Clinical Practice
|
October 27, 2018
Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations
Tiago A Mestre, Monica Busse, Aileen M Davis, et al.
Science Translational Medicine
|
December 17, 2020
Mutant huntingtin and neurofilament light have distinct longitudinal dynamics in Huntington's disease
Filipe B Rodrigues, Lauren M Byrne, Rosanna Tortelli, et al.
BJU International
|
May 28, 2021
Growth and renal function dynamics of renal oncocytomas in patients on active surveillance
Joana B Neves, Rebecca Varley, Stefano Agnesi, et al.
Page
of 7